|
|
|
|
01-Jun-2012
Purpose: To identify a cohort of women treated with neoadjuvant chemotherapy and mastectomy for...
|
|
19-May-2012
Purpose
Because insurers use performance and quality metrics to inform reimbursement, identifying...
|
|
19-May-2012
Purpose
Prolonged and disabling fatigue is prevalent after cancer treatment, but the early natural...
|
|
19-May-2012
Triple-negative breast cancer (TNBC) accounts for 15% to 20% of breast cancers. It is a...
|
|
19-May-2012
Progesterone receptor (PgR) controls the menstrual cycle, pregnancy, embryonic development, and...
|
|
15-May-2012
The Radio 4 Today programme heralded a day of wall to wall epigenetics. “Every now and then a new...
|
|
15-May-2012
Cancer cells are long known to exhibit increased aerobic glycolysis, but glycolytic inhibition has...
|
|
15-May-2012
Increasing evidence suggests that HER2-amplified breast cancer cells use HER3/ErbB3 to drive...
|
|
08-May-2012
Purpose
The Cancer and Leukemia Group B (CALGB) C9343 trial found that adjuvant radiation therapy...
|
|
03-May-2012
New England Journal of Medicine, Volume 366, Issue 18, Page 1738-1740, May 2012.
|
|
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
European Society for Medical Oncology, 2009
|
|
National Comprehensive Cancer Network, 2009
|
|
American Society of Clinical Oncology, 2005
|
|
National Comprehensive Cancer Network, 2009
|
|
European Society for Medical Oncology, 2009
|
|
